Lykos Therapeutics
Lykos, FDA Discuss Phase 3 MDMA Trial Plans
Experts Urge Further Study on Psychotherapy’s Influence on MDMA Therapy
Lykos Therapeutics Shakeup Continues With Leadership Change
Analysis: MDMA Setback Shows Psychedelic Medicine Still Has Work Ahead
Lykos Appoints Finance Veteran Scott Giacobello to Board of Directors
1 2